journal article
Download Only Collection
Abortion-pill ruling threatens FDA’s authority, say drug firms
2023 Nature
doi: 10.1038/d41586-023-01044-7pmid: 37041288
A US judge’s decision to overturn the approval of mifepristone could put other drugs at risk, pharmaceutical-industry executives warn.